Академический Документы
Профессиональный Документы
Культура Документы
The Problem
In this coursework I will be answering the following question ‘How effective are the
treatments for emphysema?’ Emphysema is a progressive lung disease that results in shortness
of breath and reduces your capacity for physical activity. Emphysema is classified under the
diseases called chronic obstructive pulmonary disease or COPD {1} (pulmonary refers to the
lungs).
Unlike heart disease and other more common causes of death, the death rate for COPD
appears to be rising. According to NHS Choices, around 900,000 people in the UK have been
diagnosed with COPD, but it is thought that another 450,000 may have it without realising it.
COPD causes 30,000 deaths a year. COPD accounts for more time off work than any other
illness. A flare-up (exacerbation) of COPD is also one of the commonest reasons for being
admitted to hospital in the UK. {2} Emphysema changes the anatomy of the lung many ways.
Emphysema is called an ‘obstructive’ lung disease because the destruction of lung tissue around
smaller sacs, called alveoli, makes these air sacs unable to hold their functional shape
upon exhalation. In people with emphysema, lung inflammation
destroys these fragile walls of the air sacs which cause them to lose
their elasticity. This reduces the support of the airways, causing
them to narrow. It also means the lungs are not as efficient at
getting oxygen into the body, causing breathing to be difficult,
hence resulting in shortness of breath.
There are many ways in which emphysema in a person develops. Smoking is by far the
single most clearly established environmental risk factor for emphysema and chronic bronchitis.
One in 5 persons who smoke develops COPD, and 80-90% of COPD patients have a smoking
history. {6} The damage begins when tobacco smoke temporarily paralyzes the microscopic
hairs (cilia) that line your bronchial tubes. Normally, these hairs sweep irritants and germs out of
your airways. But when smoke interferes with this sweeping movement, irritants remain in your
bronchial tubes and infiltrate the alveoli, inflaming the tissue and eventually breaking down
elastic fibers. Women smokers are nearly 13 times as likely to die from COPD as are women
who have never smoked. Men smokers are nearly 12 times as
likely to die from COPD as men who have never smoked. {7}
Cigarettes contain many hazardous substances that damage the
lung when inhaled, including tar nicotine, carbon monoxide, and
cyanide. Long-term exposure to secondhand tobacco smoke, air
pollution, and repeated respiratory infections also can increase a
person's risk for COPD. Industrial exposures, such as toxic fumes
or dust, can significantly increase a person's risk of COPD as well.
Testing of emphysema
Pulse oximetry test involves the use of a small device that attaches to your fingertip.
The oximeter measures the amount of oxygen in your blood differently from the way it's
measured in a blood gas analysis. {14} To help determine whether you need supplemental
oxygen, the test may be performed at rest, during exercise and overnight.
Computerized tomography (CT) scan allows your doctor to see your organs in two dimensional
images or "slices." Split-second computer processing creates these images as a series of very thin
X-ray beams are passed through your body. A CT scan can detect emphysema sooner than an
ordinary chest X-ray can, but it can't assess the severity of emphysema as accurately as can a
pulmonary function test. {15}
Treatments for Emphysema
There are many treatments to emphysema. Stopping smoking is one of the main ones
doctors recommend to the patients. Stopping smoking may cut short the progression of the
disease and should recover the function of the lungs to some degree. Doctors can prescribe drugs
to help break the addiction and can also recommend behavioral therapies, such as the NHS
support groups. Bronchodilator drugs cause the air passages in the respiratory system to open
more effusive and allow enhanced air exchange. The most common bronchodilator for mild
cases of emphysema is Salbutamol. It reacts fast and one dose usually provides relief for 4-6
hours. Salbutamol is most frequently available as a metered-dose inhaler or MDI, and this is the
way that it will be used most often for mild emphysema. The problem with Salbutamol drugs is
that it can interact with body chemicals altering the blood level without warning. For this reason,
doctors prescribe Salbutamol carefully; as it does have a dangerous side effect.
Lung volume reduction surgery may be an alternative for patients who experience
breathlessness, and have pulmonary function tests that show brutal obstacle and inflamed lungs.
Lung volume reduction surgery (LVRS) is a calming treatment that aims to remove the least
functional part of the lungs in order to advance airflow, diaphragm and chest wall procedure and
alveolar gas exchange in the remaining segment of the lung. A CT and perfusion scan are used
to identify the diseased lung tissue. The diseased part of the lung can be accessed by various
techniques including median sternotomy. Median sternotomy involves cutting through the
sternum to open the chest. {16}The procedure involves making a number of small openings in
both sides of the chest to allow the placing of instruments into the chest between the ribs. The
aim of the surgery is to reduce the volume of each lung by between 20 and 30%. This is done by
using a surgical stapling device to cut and seal the tissue, laser ablation to shrink lung volume or
a combination of both. Buttressing materials may be used along the staple line to prevent air
leaks following resection. Once the tissue has been removed the lung is re-inflated and the chest
closed.
In one study of 250 patients, 45.2% of patients (113/250) experienced prolonged air leaks
lasting more than 7 days, with 8 patients (3.2%) requiring a subsequent operation. Other
complications in this series included pneumonia (24/250), in-hospital mortality (12/250),
myocardial infarction (5/250), deep vein thrombosis (4/250), small bowel obstruction (6/250),
and phrenic nerve injury (2/250). {16}
References
1) http://www.emedicinehealth.com/chronic_obstructive_pulmonary_disease_co
pd/article_em.htm
2) http://www.webmd.boots.com/a-to-z-guides/emphysema
3) http://emphysema.org/
4) http://www.wrongdiagnosis.com/e/emphysema/intro.htm
5) Figure 1: http://www.google.co.uk/imgres?
imgurl=http://cdn.nursingcrib.com/wp-
content/uploads/emphysema.jpg&imgrefurl=http://www.blupress.it/telefilmsh
ow/c.o.p.d.-disease
6) http://emedicine.medscape.com/article/298283-overview
7) http://www.umm.edu/careguides/000108.htm
8) Figure 2: http://knol.google.com/k/-/-/W7JzU7Dr/LKNTdA/FemaleDeaths.jpg
9) http://www.cancer.gov/cancertopics/factsheet/Tobacco/ETS
10) http://www.scribd.com/doc/11823200/Emphysema
11) http://knol.google.com/k/chronic-obstructive-pulmonary-disease-copd#
12) http://www.scribd.com/doc/11823200/Emphysema
13) http://www.scribd.com/doc/11823200/Emphysema.uk
14) http://www.businessweek.com/lifestyle/content/healthday/650728.html
15) http://www.mayoclinic.com/health/emphysema/DS00296/DSECTION=te
sts-and-diagnosis
16) http://www.nice.org.uk/nicemedia/live/11139/31247/31247.pdf
17) http://www.umm.edu/thoracic/lvrs_success.htm